$66.27
Price
$3.2B
Market Cap
17.5
P/E Ratio
13.8
Forward P/E
$3.79
EPS (TTM)
—
Dividend Yield
$62M
Cash
$1.0B
Total Debt
47M
Shares Out
$57.25
$90.04
52-Week Range
Institutional Ownership of PRESTIGE CONSMR HEALTHCARE I
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PRESTIGE CONSMR HEALTHCARE I
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +63.2% | 3.6M | $224M | $66.75 | |
| BUY | +75.0% | 21.0K | $1M | $66.75 | |
| 2025-Q2 | |||||
| SELL | -12.6% | 2.2M | $176M | $84.19 | |
| SELL | -20.0% | 12.0K | $958000 | $84.19 | |
| 2025-Q1 | |||||
| SELL | -8.8% | 2.5M | $217M | $84.21 | |
| SELL | -42.3% | 15.0K | $1M | $84.21 | |
| 2024-Q4 | |||||
| SELL | -0.8% | 2.8M | $216M | $78.72 | |
| SELL | -25.7% | 26.0K | $2M | $78.72 | |
| 2024-Q3 | |||||
| SELL | -1.9% | 2.8M | $201M | $70.81 | |
| SELL | -28.6% | 35.0K | $3M | $70.81 | |
| 2024-Q2 | |||||
| BUY | +10.7% | 2.8M | $195M | $68.63 | |
| BUY | +25.6% | 49.0K | $3M | $68.63 | |
| 2024-Q1 | |||||
| BUY | +0.2% | 2.6M | $186M | $68.76 | |
| SELL | -9.3% | 39.0K | $3M | $68.76 | |
| 2023-Q4 | |||||
| BUY | +0.8% | 2.6M | $156M | $59.43 | |
| 2023-Q3 | |||||
| BUY | +173.8% | 2.5M | $145M | $59.22 | |
| SELL | -12.2% | 43.0K | $2M | $59.22 | |
| 2023-Q2 | |||||
| BUY | +7.8% | 925.7K | $55M | $59.23 | |
| 2023-Q1 | |||||
| BUY | +3.1% | 859.1K | $54M | $61.36 | |
| BUY | +2.8% | 49.0K | $3M | $61.36 | |
| 2022-Q4 | |||||
| SELL | -4.9% | 833.4K | $52M | $58.44 | |
| SELL | -51.3% | 47.7K | $3M | $58.44 | |
| 2022-Q3 | |||||
| BUY | +15.3% | 876.7K | $44M | $56.60 | |
| BUY | +60.5% | 97.9K | $7M | $56.60 | |
| 2022-Q2 | |||||
| BUY | NEW | 760.2K | $45M | $54.88 | |
| SELL | -10.3% | 61.0K | $4M | $54.88 | |
| 2022-Q1 | |||||
| SELL | -6.8% | 68.0K | $4M | $58.37 | |
| 2021-Q4 | |||||
| SELL | -15.1% | 73.0K | $4M | $59.04 | |
| 2021-Q3 | |||||
| SELL | -18.9% | 86.0K | $5M | $53.78 | |
| 2021-Q2 | |||||
| SELL | -1.9% | 106.0K | $6M | $48.91 | |
| 2021-Q1 | |||||
| BUY | +28.6% | 108.0K | $5M | $42.20 | |
| 2020-Q4 | |||||
| BUY | +104.9% | 84.0K | $3M | $35.86 | |
| 2020-Q3 | |||||
| BUY | +10.8% | 41.0K | $1M | $37.19 | |
| 2020-Q2 | |||||
| SELL | -17.8% | 37.0K | $1M | $40.12 | |
| 2020-Q1 | |||||
| SELL | -29.7% | 45.0K | $2M | $39.81 | |
| 2019-Q4 | |||||
| SELL | -16.9% | 64.0K | $3M | $37.61 | |
| 2019-Q3 | |||||
| SELL | -22.2% | 77.0K | $3M | $32.66 | |
| 2019-Q2 | |||||
| SELL | -12.4% | 99.0K | $3M | $29.70 | |
| 2019-Q1 | |||||
| BUY | +15.5% | 113.0K | $3M | $28.52 | |
| SELL | EXIT | — | — | $28.52 | |
| 2018-Q4 | |||||
| SELL | -12.1% | 97.8K | $3M | $37.73 | |
| BUY | +47.0% | 10.6K | $326000 | $37.73 | |
| 2018-Q3 | |||||
| SELL | -17.1% | 111.3K | $4M | $38.12 | |
| BUY | +9.1% | 7.2K | $272000 | $38.12 | |
| 2018-Q2 | |||||
| SELL | -15.9% | 134.3K | $5M | $33.91 | |
| BUY | NEW | 6.6K | $253000 | $33.91 | |
| 2018-Q1 | |||||
| BUY | +48.1% | 159.8K | $5M | $36.17 | |
Insider Trading for PRESTIGE CONSMR HEALTHCARE I
6 Months Insider Sentiment
Buy $0
Sell $238K
0
Buys
3
Sells
-238K
Net
0
Grants
Largest
$178K
Byom
$43K
Zerillo
$17K
Zerillo
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 01, 2025 | Jeffrey Zerillo | Senior VP Operations | SELL | 281 | $60.00 | $17K |
| Nov 28, 2025 | Jeffrey Zerillo | Senior VP Operations | SELL | 719 | $60.00 | $43K |
| Nov 25, 2025 | John E Byom | Director | SELL | 3.0K | $59.35 | $178K |